Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$9.56bn	152.61	n/a
MSBMesoblast	AU$2.06bn	n/a	n/a
OPTOpthea	AU$738.75m	n/a	n/a
CU6Clarity Pharmaceuticals	AU$734.66m	n/a	n/a
PYCPYC Therapeutics	AU$650.33m	n/a	n/a
IMMImmutep	AU$363.90m	n/a	n/a
DXBDimerix	AU$253.83m	n/a	n/a
CGSCogstate	AU$230.37m	20.23	n/a
IMUImugene	AU$193.42m	n/a	n/a
RACRace Oncology	AU$176.32m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$116.83m	n/a	n/a
ALAArovella Therapeutics	AU$104.88m	n/a	n/a
ACWActinogen Medical	AU$87.72m	n/a	n/a
PEBPacific Edge	NZ$92.56m	n/a	n/a
AGNArgenica Therapeutics	AU$86.46m	n/a	n/a
SNTSyntara	AU$85.27m	n/a	n/a
LTPLtr Pharma	AU$67.87m	n/a	n/a
GD8GO-DX (Aust)	AU$61.94m	n/a	n/a
PIQProteomics International Laboratories	AU$51.09m	n/a	n/a
BXNBioxyne	AU$49.18m	18.18	n/a